Inventor

SENDZIK MARTIN

US38 patents

⚠️ This page may combine multiple inventors who share the name “SENDZIK MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SENDZIK MARTIN

NOVARTIS AG

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2

Compounds and compositions for inhibiting the activity of SHP2

Triazolopyrimidine compounds and uses thereof

Compounds and compositions for inhibiting the activity of SHP2

Triazolopyridine compounds and uses thereof

Imidazolepyridine compounds and uses thereof

Triazolopyrimidine compounds and uses thereof

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

Heteroaryl compounds and their uses

Compounds and compositions as RAF kinase inhibitors

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

Triazolopyrimidine compounds and uses thereof

Compounds and compositions for inhibiting the activity of SHP2

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

PHARMACYCLICS INC

Hydroxamates as therapeutic agents

Hydroxamates as therapeutic agents

Hydroxamates as therapeutic agents

Hydroxamates as therapeutic agents

Acetylene derivatives as inhibitors of histone deacetylase

CHEN ZHUOLIANG

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2

Compounds and compositions for inhibiting the activity of SHP2

CAFERRO THOMAS RAYMOND

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

CHEN CHRISTINE HIU TUNG

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

ALBAUGH PAMELA

Compounds and compositions as protein kinase inhibitors

NOVARTIS VACCINES & DIAGNOSTIC

6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling

VERNER ERIK J

Hydroxamates as therapeutic agents

CHAN HO MAN

Triazolopyrimidine compounds and uses thereof

CYTOVIA INC

Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof

HUANG ZILIN

Heterocyclic compounds and uses thereof

SUTTON JAMES C

6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling

BARSANTI PAUL A

Heteroaryl compounds and their uses

HUNAG ZILIN

Heteroaryl-substituted imidazole compounds and uses thereof

PHARMACYCLICS LLC

Hydroxamates as therapeutic agents

NG SIMON C

CSF-1R inhibitors, compositions, and methods of use